Cencora Inc. closed 3.50% below its 52-week high of $296.65, which the company reached on April 4th.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. Mid-cap ...

Cencora COR -0.56% Get Free Report has outperformed the market over the past 5 years by 12.25% on an annualized basis ...

Shares of Cencora Inc. COR shed 1.95% to $281.16 Monday, on what proved to be an all-around grim trading session for the ...

In its first-quarter 2025 investor letter, Carillon Eagle Mid Cap Growth Fund highlighted stocks such as Cencora, Inc. (NYSE:COR). Cencora, Inc. (NYSE:COR) is a pharmaceutical products distributor.

Has Cencora (COR) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out. Cencora is a member of our Medical group, which includes 1002 ...

Valued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in ...

Valued at a market cap of $54.8 billion, Cencora, Inc. (COR) is a global healthcare solutions provider. Headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and ...